Boehringer Ingelheim's Johannes Schoen on the Evolution of Pharma Logistics
Add bookmarkIn this interview Johannes Schoen, Supply Network Quality Management Anti-counterfeiting, Boehringer Ingelheim, speaks to Andrea Charles from Cold Chain IQ, about how he sees pharma logistics evolving in the next 2-3 years and what big changes we can expect. Schoen also highlights the key challenges to creating a safe and secure supply chain that measures against counterfeiting and discusses the impact the Falsified Medicines Directive is having on the industry.
This interview was filmed Cool Chain Logistics Europe 2013.
 |
|
Have Your Say Rate this feature and give us your feedback in the comments section below |
In this interview Johannes Schoen, Supply Network Quality Management Anti-counterfeiting, Boehringer Ingelheim, speaks to Andrea Charles from Cold Chain IQ, about how he sees pharma logistics evolving in the next 2-3 years and what big changes we can expect. Schoen also highlights the key challenges to creating a safe and secure supply chain that measures against counterfeiting and discusses the impact the Falsified Medicines Directive is having on the industry.
